Avadel Pharmaceuticals plc (NASDAQ: AVDL) Stock Information | RedChip

Avadel Pharmaceuticals plc (NASDAQ: AVDL)


$11.3100
+0.5600 ( +5.31% ) 449.4K

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

Market Data


Open


$11.3100

Previous close


$10.7500

Volume


449.4K

Market cap


$1.06B

Day range


$10.6780 - $11.5600

52 week range


$10.4100 - $19.0900

SEC Filings


Form Type Description Pages Date
ars Annual reports 1 Jun 18, 2024
3 Insider transactions 2 May 21, 2024
8-k 8K-related 15 May 21, 2024
4 Insider transactions 1 May 21, 2024
10-q Quarterly Reports 68 May 08, 2024
8-k 8K-related 15 May 08, 2024
8-k 8K-related 14 May 08, 2024
3 Insider transactions 2 May 03, 2024
10-k/a Quarterly Reports 13 Apr 26, 2024
8-k 8K-related 13 Apr 15, 2024

Latest News